Effect and neural mechanisms of the transcutaneous vagus nerve stimulation for relapse prevention in patients with remitted major depressive disorder: protocol for a longitudinal study

INTRODUCTION: After the first episode, patients with remitted major depressive disorder (MDD) have a 60% chance of experiencing a second episode. There are currently no accepted, effective methods to prevent the recurrence of MDD in remission. Transcutaneous vagus nerve stimulation (taVNS) is a non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhu-Qing, Guo, Zhi-Peng, Lv, Xue-Yu, Sörös, Peter, Wang, Xiao-Xu, Wang, Lihong, Liu, Chun-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Mental Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867334/
https://www.ncbi.nlm.nih.gov/pubmed/35193903
http://dx.doi.org/10.1136/bmjopen-2021-050446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867334/
https://www.ncbi.nlm.nih.gov/pubmed/35193903
http://dx.doi.org/10.1136/bmjopen-2021-050446

Ejemplares similares